Quality of life (QOL) for patients with esophageal cancer receiving trimodality therapy with induction chemotherapy, chemoradiation, and surgery: Results from CALGB 80803 (alliance) Meeting Abstract
| Authors: | Goodman, K. A.; Dueck, A. C.; Fruth, B.; Noonan, A. M.; Shergill, A.; Bekaii-Saab, T. S.; O'Reilly, E. M.; Meyerhardt, J. A.; Ilson, D. H.; Deshields, T. L. |
| Abstract Title: | Quality of life (QOL) for patients with esophageal cancer receiving trimodality therapy with induction chemotherapy, chemoradiation, and surgery: Results from CALGB 80803 (alliance) |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500276 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.283 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 283 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
